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Abstract: Congenital fibrosis of the extraocular muscles (CFEOM) is a congenital cranial dysinnerva-
tion disorder caused by developmental abnormalities affecting cranial nerves/nuclei innervating the
extraocular muscles. Autosomal dominant CFEOM arises from heterozygous missense mutations
of KIF21A or TUBB3. Although spatiotemporal expression studies have shown KIF21A and TUBB3
expression in developing retinal ganglion cells, it is unclear whether dysinnervation extends beyond
the oculomotor system. We aimed to investigate whether dysinnervation extends to the visual system
by performing high-resolution optical coherence tomography (OCT) scans characterizing retinal
ganglion cells within the optic nerve head and retina. Sixteen patients with CFEOM were screened
for mutations in KIF21A, TUBB3, and TUBB2B. Six patients had apparent optic nerve hypoplasia.
OCT showed neuro-retinal rim loss. Disc diameter, rim width, rim area, and peripapillary nerve
fiber layer thickness were significantly reduced in CFEOM patients compared to controls (p < 0.005).
Situs inversus of retinal vessels was seen in five patients. Our study provides evidence of structural
optic nerve and retinal changes in CFEOM. We show for the first time that there are widespread
retinal changes beyond the retinal ganglion cells in patients with CFEOM. This study shows that the
phenotype in CFEOM extends beyond the motor nerves.
Keywords: congenital fibrosis of extraocular muscles; optic nerve hypoplasia; optical coherence
tomography; retinal ganglion cells; development; congenital cranial dysinnervation disorders
1. Introduction
Congenital fibrosis of the extraocular muscles (CFEOM) is a congenital cranial dysin-
nervation disorder characterized by non-progressive ophthalmoplegia with or without
blepharoptosis [1]. CFEOM is genetically heterogeneous and can be further classified
into several subtypes, namely CFEOM1A, CFEOM1B, CFEOM2, CFEOM3A, CFEOM3B,
CFEOM3C, Tukel syndrome, and CFEOM3 with polymicrogyria [2]. The minimum preva-
lence of this disorder was found to be 1:230,000 [3]. CFEOM1 is the most common subtype
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and typically presents with bilateral congenital non-progressive restrictive ophthalmople-
gia with the eyes partially or fully fixed in depression, limited upgaze, and blepharop-
tosis [3]. CFEOM1 is inherited in an autosomal dominant manner and can arise from
mutations of KIF21A (CFEOM1A) [4] or TUBB3 (CFEOM1B) [5]. CFEOM2 is characterized
by congenital non-progressive bilateral exotropic ophthalmoplegia and blepharoptosis.
Vertical and horizontal eye movements are severely restricted, and sluggish pupillary
reactions to light have been described [6]. CFEOM2 is inherited in an autosomal recessive
manner and arises from PHOX2A mutations [7]. CFEOM3 has variable clinical features,
which can include varying degrees of congenital non-progressive external ophthalmoplegia
and blepharoptosis. The severity can range from mild to complete ophthalmoplegia and
can be unilateral or bilateral [5]. There can be significant overlap of phenotypical features
with CFEOM1 or CFEOM2, and thus they can be clinically indistinguishable. CFEOM3
is inherited in an autosomal dominant manner and arises from TUBB3 or TUBB2B muta-
tions [5]. Recently we have reported that congenital monocular elevation deficiency, or
double elevator palsy, can be part of CFEOM3 and arise from TUBB3 mutations [8].
Magnetic resonance imaging (MRI) studies in CFEOM secondary to KIF21A and
TUBB3 mutations have provided evidence for widespread orbital dysinnervation, which
can include optic nerve hypoplasia [9,10]. Clinical examination aided by fundus photos
have also been used to describe disc excavation and optic nerve hypoplasia in CFEOM1
and CFEOM3; however, sequence analysis only identified one patient with a KIF21A
mutation [11,12]. Retinal dysfunction has been identified in CFEOM2 with delayed or
depressed rod and cone responses detected on electroretinogram (ERG) [13]. These stud-
ies suggest abnormalities in CFEOM extend beyond motor nerves and can involve the
optic nerve and retina as well. Spectral domain optical coherence tomography (SD-OCT)
provides an opportunity to perform non-invasive high-resolution in vivo imaging of the
retina and optic nerve head. However, to date, there have been no studies using OCT to
investigate the retinal or optic nerve head morphology in CFEOM. The advent of handheld
ultra-high-resolution SD-OCT enables detailed characterization of the retina and optic
nerve head morphology in pediatric populations and patients who find it difficult to use a
table-mounted OCT device due to abnormal head posture or large angle strabismus [14].
In this study, we aimed to genotype a cohort of patients with CFEOM and also to uti-
lize a handheld SD-OCT to phenotypically characterize the optic nerve head and foveal
morphology in patients with CFEOM.
2. Results
2.1. Clinical and Genetic Characteristics
The pedigrees and characteristics of individuals diagnosed with CFEOM are shown in
Figure 1A and Supplementary Table S1, respectively. The phenotypes and genotypes
associated with families F1 [8] and F4 [15] and subject S1:II-1 [4,16] have previously
been described.
Affected subjects in F1 had significant intra-familial clinical variability and each
harbored a heterozygous TUBB3 mutation (c.1263G > C, p.Glu421Asp) [8]. Subject F1:I-1
had bilateral blepharoptosis, left esotropia, and bilateral restriction on elevation (Figure 1B);
however, both his children (F1:II-1 and F1:II-2) had unilateral restriction without ptosis
(Figure 1B) [8].
Both subjects in family F2 had bilateral blepharoptosis and restrictive ophthalmo-
plegia. Subject F2:I-2 had asymmetrical ptosis, Marcus Gunn jaw winking phenomenon,
and synergistic divergence (Figure 1C–F). The daughter (subject F2:II-1) had synergistic
divergence (Figure 1G,H). Mutation screening was unrevealing.
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Figure 1. (A) Pedigrees of families (F1–F4) and singletons (S1–S4) diagnosed with congenital fibrosis of the extraocular
muscles. Genotypes are shown below the pedigrees. (B) Eye position in subjects with congenital fibrosis of extraocular
muscles when observing a target located centrally (primary position) and superiorly (upgaze). Subject F1:I-1 has bilateral
blepharoptosis, left esotropia, and no elevation in both eyes. However, his son (subject F1:II-3) has CFEOM3 phenotype
limited to the right eye; he is unable to elevate the eye above the midline. There was no blepharoptosis and ductions were
normal for the left eye. Subject F3:I-2 and subject S1:II-1 exhibited a CFEOM1 phenotype with bilateral blepharoptosis
and inability to elevate either eye. Subject F3:I-2 also had a left exotropia and hypotropia. (C–H) Congenital pathologic
synkinesis showing Marcus Gunn jaw winking phenomenon and synergistic divergence. Subject F2:I-2 had bilateral
blepharoptosis, face turn to the left, and left exotropia with hypotropia (C). Retraction of the left upper eyelid is observed
with mouth opening (D). Eye positions on central fixation (E) and downgaze (F) are shown. Synkinetic abduction of the left
eye is observed on infraversion. Similar to F2:II-1, there is synkinetic abduction from central fixation (G) to downgaze (H).
(I–P) Abnormal head postures observed when fixing at a target centrally in family F4 (I–L). Subjects F4:I-2 (I) and F4:II-1 (J)
exhibit chin up and face turn to the left. Subject F4:II-2 has a head turn to the right with chin up position (K). Subject F4:II-3
has head tilt to the right with chin up position (L). All subjects had large angle exotropia. Facial weakness is demonstrated
in all subjects when asked to smile (M–O). Drooping of the corner of the mouth and flattening of forehead and nasolabial
folds are seen. Subject F4:II-3 had severe blepharoptosis of the left eye and frequently raised his upper left eyelid and brow
using his finger in order to fixate with the left eye (P).
Int. J. Mol. Sci. 2021, 22, 2575 4 of 13
Affected members of family F3 had bilateral blepharoptosis and restrictive ophthalmo-
plegia consistent with CFEOM1 (Figure 1B), and each had a heterozygous KIF21A mutation
(c.2860C > T, p.(Arg954Trp)—Supplementary Figure S1).
Affected members of family F4 had bilateral blepharoptosis, severe restrictive oph-
thalmoplegia, facial weakness, anosmia, and intellectual disability; the mother (F4:I-2)
harbored a de novo heterozygous TUBB3 mutation (c.1228G > A, p.(Glu410Lys)), which
then segregated with the phenotype in all three of her children [15].
Singletons S1:II-1, S2:II-1, and S4:II-1 had bilateral ptosis with limited supraduction.
S1:II-1 had a de novo heterozygous KIF21A mutation (c.2860C > T, p.(Arg954Trp)) and, as
a child, had right hypertropia observed during tooth brushing [4,16]. Sequence analysis
in singleton S2:II-1 revealed a rare variant in TUBB3 (c.229C > T, p.(Arg77Cys)) inherited
from his unaffected mother (Supplementary Figure S1). This variant was absent in his
unaffected father and sister. It is located within the GTPase domain and, based on in silico
analysis, is predicted to be disease-causing by MutationTaster and benign by PolyPhen-2
(Supplementary Table S2). This residue is moderately conserved with a GERP score of
4.57. It is absent from dbSNP and gnomAD, although R77H is in gnomAD once in the
heterozygous state (3.98 × 10−6). Overall, based on ACMG criteria, this was classified as a
variant of unknown significance. S3:II-1 had unilateral ptosis with limited vertical gaze,
and both singletons S3 and S4 remain genetically unsolved with no mutations in KIF21A,
PHOX2A, TUBB3, or TUBB2B. There was no family history of strabismus in S3 or S4.
Subject F1:I-1 had been diagnosed with primary open-angle glaucoma and was subse-
quently excluded from the optic nerve and foveal analysis. All other subjects had normal
intraocular pressures and no other ocular co-morbidities. Confrontational visual fields
were grossly normal, and cooperation was poor in F4:II-1, F4:II-2, and F4:III-3. There was
no relative afferent pupillary defect in any of the patients.
The mean BCVA were 0.36 ± 0.09 logMAR (right eye) and 0.56 ± 0.13 logMAR (left
eye) (mean ± SEM). Eleven subjects were diagnosed with amblyopia with a mean inte-
rocular visual acuity difference of 0.36 logMAR (range 0.2–0.8 logMAR). The mean BCVA
(excluding amblyopic eyes) in the CFEOM subjects was 0.31 ± 0.10 logMAR (mean ± SEM).
This suggests that there was subnormal vision even after accounting for amblyopia.
2.2. Optic Nerve Abnormalities
Optic disc examination revealed features such as peripapillary atrophy and double-
ring sign (see examples in Figure 2 and Supplementary Table S1). Partial double-ring
sign or atrophy was seen in 6/16 (38%) patients (Figures 2 and 3). Tilted discs were seen
in 2/16 (13%) patients. Interestingly, fundus photos showed healthy neuro-retinal rims
with small cups in six patients; however, the OCT revealed large excavated cups, thus
giving a pseudo-normal appearance on fundus examination (Figure 3). Subject F3:II-2 has
a yellow central area mimicking the cup in fundus photos; however, OCT shows a deep
cup with thin neuro-retinal rims. There was a significant difference between the cup/disc
ratio based on fundus photos/clinical examination and OCT. The cup/disc ratio based on
fundus photos (mean ± SEM = 0.42 ± 0.06) was significantly smaller (p = 0.0003) when
compared to OCT measurements (mean ± SEM = 0.76 ± 0.03). In all cases, the cup/disc
ratio was underestimated on fundus photos/clinical examination. OCT through the double
ring shows loss of RPE with hyper-reflectivity posterior to Bruch’s membrane (scan 2 in
Figure 3). Similarly, in peripapillary atrophy we find abnormal sloping of the RPE and
hyper-reflectivity posterior to the RPE (scan 8 in Figure 3).
Reliability analyses between examiners revealed high intraclass correlation coefficients
for disc diameter (0.93; 95% CI = 0.86–0.96), rim width (0.90; 95% CI = 0.80–0.95), cup
diameter (0.96; 95% CI = 0.93–0.98), and cup depth (0.96; 95% CI = 0.92–0.98).
Quantitative analysis showed that the horizontal disc diameter width was signifi-
cantly reduced in CFEOM patients compared to controls (Figure 4F, mean difference ±
standard error of mean (MD ± SEM) = 168.8 ± 55.9 µm, p = 0.0048). Rim width (Figure 4G,
MD ± SEM = 527.5 ± 80.3 µm, p < 0.0001) and total rim area (Figure 4H, MD ± SEM =
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109872.4 ± 15264.4 µm2, p < 0.0001) were significantly reduced in CFEOM. Cup width
(Figure 4I, MD ± SEM = 346.2 ± 92.9 µm p = 0.001), cup depth (Figure 4J, MD ± SEM =
127.3 ± 48.3 µm, p = 0.014), and cup area (Figure 4K, MD ± SEM = 153535.2 ± 46908.8 µm2,
p = 0.003) were significantly increased in CFEOM compared to controls. Cup/disc ra-
tio was significantly larger in CFEOM compared to controls (Figure 4L, MD ± SEM =
0.29 ± 0.05, p < 0.0001). RNFL thickness was significantly reduced both nasally (Figure 4M,
MD ± SEM = 14.4 ± 4.5 µm, p = 0.004) and temporally (Figure 4N, MD ± SEM =
9.7 ± 3.2 µm, p = 0.005).
No significant correlation was seen between visual acuity and optic nerve head
parameters (disc diameter, rim width, rim area, and RNFL thickness) (p > 0.05).
Figure 2. Fundus photos of subjects with CFEOM. In subject F3:1-2, the disc appears tilted with a
small cup and inferior yellowish mottled halo (blue arrows). There is situs inversus of the blood
vessels. Subject S1:II-1 has a faint halo surrounding the disc, which is a subtle incomplete double
ring (yellow arrows). This is also seen in the left eye of subject F3:III-1, with an abnormal course of
retinal vessels seen in both eyes. Subject F3:II-2 has hypoplastic optic nerves with significant inferior
peripapillary scleral halos (blue arrows). Abnormal course of retinal vessels is seen. Subject F1:I-1
has tilted disc with myopic crescent (white arrow) and significant disc excavation and pallor. Scale
bar represents 500 microns.
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Figure 3. Optical coherence tomograms with corresponding disc photos. Dotted white line represents location of the OCT
B-scan overlaid on the disc photo. Schematic shows borders of disc (orange) with the cup centrally (yellow), double ring
(pale yellow), and peripapillary atrophy (hatched). Partial double ring/atrophy (F3:I-2 and F3:II-2) is seen below disc
border (white arrows). In subject F3:I-2, the first scan (1) shows thin temporal neuro-retinal rim (yellow arrow); this is not
evident on the disc photo as the borders of the cup are not clear and the cup appears significantly smaller. The location of
the neuro-retinal rim on the fundus photo is highlighted with the yellow arrow. The second scan (2) is through a region
of yellow mottled appearance. The OCT shows a hyper-reflective region posteriorly (white arrow). Disc photo of subject
F3:II-2 shows appearance of a small cup. However, on OCT (3) the rim is very thin (yellow arrow), and the cup is deep and
appears larger than on the fundus photo. The OCT through the inferior aspect of the disc (4) shows an optic cup that is not
evident on the fundus photo. Disc photo in F3:III-1 shows a small cup with large neuro-retinal rims. However, OCT (5)
shows thin neuro-retinal rim temporally (yellow arrow). OCT (6) below the inferior border of the presumed cup (from the
fundus photo and illustration) shows a well-formed cup, although not as deep as the OCT through the center of the cup (5).
In subject F1:I-1, this abnormal sloping is evident in the region of peripapillary atrophy (white arrow) in both scans (7,8).
There is also a thin neuro-retinal rim with good correlation between disc photos and the OCT (yellow arrow).
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Figure 4. Schematic representation based on average measurements of disc parameters in CFEOM (A) and controls (B).
Examples of disc optical coherence tomograms in CFEOM patients and controls (C–E). Yellow lines represent the horizontal
disc diameters measured from the termination of the retinal pigment epithelium. Graphs show mean and error bars
representing the standard error of mean for disc diameter (F), rim width (G), rim area (H), cup width (I), cup depth (J),
cup area (K), cup/disc ratio (L), nasal nerve fiber layer (NFL), thickness (M), and temporal NFL thickness (N). p values are
shown above error bars.
2.3. Retinal Vascular Abnormalities
We obtained fundus photos in 13 patients. In 4/13 patients the central retinal vessels
emerge off-center or from the peripheral part of the optic nerve, and the temporal vessels
course nasally before turning temporally—features consistent with a situs inversus pattern
(Figure 2 and Supplementary Table S1).
No significant differences were noted in the branching geometry at the bifurcation
(angle θ, θ1, and θ2), diameter ratios (α, β, and λ), or junction exponent (K).
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2.4. Foveal and Parafoveal Abnormalities
Visual inspection of the tomograms did not reveal any gross foveal abnormalities.
However quantitative analysis showed significant differences in the parafoveal region.
Nasal parafoveal retinal thickness was significantly reduced in CFEOM compared to
controls (Figure 5C, MD ± SEM = 22.0 ± 5.6 µm, p = 0.001). This was due to a signifi-
cantly thinner RNFL (Figure 5D, MD ± SEM = 4.8 ± 0.9 µm, p < 0.0001), GCC (Figure 5E,
MD ± SEM = 8.1 ± 2.7 µm, p = 0.005), and PRL (Figure 5F, MD ± SEM = 10.8 ± 4.5 µm,
p = 0.024). Although the temporal parafoveal retinal thickness was not significantly dif-
ferent in CFEOM (p > 0.05), the RNFL (Figure 5D, MD ± SEM = 2.6 ± 0.6 µm, p = 0.0002),
GCC (Figure 5E, MD ± SEM = 7.5 ± 2.2 µm, p = 0.002), and PRL (Figure 5F, MD ± SEM =
7.9 ± 3.7 µm, p = 0.039) were significantly thinner in CFEOM compared to controls.
Figure 5. Schematic representation of average thickness of each retinal layer in CFEOM (A) and controls (B). Significant
differences were observed for nasal retinal thickness (C), retinal nerve fiber layer (RNFL) (D), ganglion cell complex (GCC)
(E), and photoreceptor layer (PRL) thickness (F). Bar charts represent mean and standard error (µm). p values are shown
above each bar. Abbreviations: RNFL = retinal nerve fiber layer, GCL = ganglion cell layer, IPL = inner plexiform layer,
INL = inner nuclear layer, OPL = outer plexiform layer, ONL = outer nuclear layer, IS = inner segment, OS = outer segment,
COST = cone outer segment tip, and RPE = retinal pigment epithelium.
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3. Discussion
This is the first study showing widespread retinal and optic nerve head changes in
patients with CFEOM. We identify that patients with CFEOM have smaller optic nerves
with deeper optic cups and significantly thinner neuro-retinal rims. The reduced visual
acuity in CFEOM could be partly attributed to the retinal and optic nerve changes seen.
However, likely due to the presence of amblyopia, we did not observe a correlation with
visual acuity. Significant retinal vascular abnormalities were seen in 4/13 patients.
The exact pathogenesis of optic nerve hypoplasia in patients with CFEOM is unclear.
However, using MRI studies, optic nerve hypoplasia has previously been described in
patients with KIF21A mutations [10] and TUBB3 mutations [9]. In CFEOM1, there is
approximately between 30% and 40% reduction in optic nerve cross-sectional area on
MRI [10]. Similarly, in CFEOM3, there is approximately 35% reduction in optic nerve
cross-sectional area [9]. In this study, we find on average approximately 10% reduction in
horizontal disc diameter. The differences between the studies are likely due to differences
in (a) imaging modalities (MRI versus SD-OCT), (b) type of measurements (cross-sectional
area versus horizontal disc diameter), and (c) location of optic nerve measurements (2 mm
from globe versus scleral opening).
On ophthalmoscopy, we could identify features of optic nerve hypoplasia, such as an
incomplete double-ring sign, in 6/16 (38%) patients. This was seen in both patients with
KIF21A and TUBB3 mutations (Supplementary Table S1). In both CFEOM1 and CFEOM3,
optic nerve hypoplasia with double-ring sign has been described [9,10,12]. In 2/10 (20%)
patients with CFEOM3, a double-ring sign has been described; both subjects had TUBB3
variants resulting in amino acid substitution R262C [12]. Khan et al. identified a higher rate
of optic nerve hypoplasia (5/10 (50%)) in CFEOM in comparison to our study and previous
work. The genetic diagnosis was only identified in 1/10 patients. Thus, the difference could
arise due to the difference in study populations, since most families studied by Khan et al.
were from consanguineous families [12].
In this study, we show that the GCC in patients with CFEOM is thinner compared
to controls. This could potentially be the basis for smaller optic nerves seen in patients
with CFEOM. Within the retina, KIF21A expression was observed in the retinal ganglion
cell bodies [17]. However, the Kif21a R954W knock-in mouse model did not demonstrate
any abnormalities in retinal ganglion cell axonal projections [18]. This suggests that
pathogenesis for the retinal phenotype observed in humans could be different from the
Kif21aKI/KI model, since the R954W variant in humans can be associated with variable
expressivity of optic nerve hypoplasia as described in this study and others [10,12].
TUBB3 has widespread expression within the developing neural retina. It is expressed
in the retinal ganglion cells, amacrine cells, horizontal cell processes, and cone photorecep-
tors [19]. In Tubb3-/- mice, there is a decrease in growth cone microtubule dynamics and a
decreased neurite outgrowth rate in peripheral axons but no developmental pathology [20].
However, the roles within retinal cell populations have not been investigated. Based on
our OCT findings and previous MRI work [9], it is possible that TUBB3 has a role in retinal
neurogenesis. However, this requires further study. Optic nerve hypoplasia has been
reported in four subjects from two consanguineous families with TUBA8 mutations and
polymicrogyria [21]. Similarly, optic nerve hypoplasia has been reported with TUBA1A
mutations [22], thus suggesting that tubulin gene mutations in general can cause optic
nerve hypoplasia [9,21,22].
We found a significantly reduced PRL in patients with CFEOM when compared to
controls. TUBB3 is expressed within the developing cone photoreceptors [19]; however,
there is no direct evidence of KIF21A involvement in photoreceptor development. Photore-
ceptor changes in CFEOM are a common but perhaps poorly explored manifestation of
this disorder. With the advent of handheld SD-OCT, it will be possible to document these
structural changes in a larger cohort of patients to identify specific genotype–phenotype
correlations. The vascular abnormalities described in this study were only associated with
KIF21A mutations. Kinesin proteins participate in intraflagellar transport to form cilia,
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which are important to direct nodal flow of extra-embryonic fluid, and thus affect the
formation of the left–right axis during development [23]. Whether this process is perturbed
due to KIF21A mutations resulting in situs inversus of retinal vessels requires further study.
In conclusion, we describe for the first time widespread optic nerve and retinal
abnormalities in CFEOM that can be detected using SD-OCT. Changes are consistent with
neuro-retinal expression patterns of KIF21A and TUBB3. OCT showed that loss of neuro-
retinal rim was much more pronounced than apparent on fundus examination, where some
of the patients had pseudo-normal discs. This expands the phenotypic spectrum associated
with CFEOM and highlights the need for further research into the molecular mechanisms
affecting development of the afferent pathways in this condition.
4. Materials and Methods
4.1. Subjects
Sixteen patients with CFEOM (8 male, 8 female; mean age ± standard deviation =
20 ± 16.80 years) from eight families and sixteen age-, gender-, and ethnicity-matched
healthy controls participated in this study. All participants underwent a complete oph-
thalmic and orthoptic examination, including best-corrected visual acuity (BCVA), ocular
motility, pupil examination, slit-lamp examination, refraction, intraocular pressure mea-
surements, and dilated fundoscopy. Fundus photos were acquired using Zeiss VisucamPRO
NM (Carl Zeiss Meditec Inc, Jena, Germany) or Pictor (Volk Optical Inc, Mentor, OH, USA).
Intraocular pressure was measured using either Goldmann applanation tonometer or iCare
rebound tonometer, TA01i (Tiolat Oy, Helsinki, Finland).
The study adhered to the tenets of the Declaration of Helsinki and was approved by
the local ethics committee. Written informed consent was obtained from all participants or
their parents or guardians.
4.2. Sequencing
Saliva samples (Oragene DNA sample Collection Kit (OG-500, DNA Genotek Inc.,
Ottawa, ON, Canada)) were obtained from all family members. DNA was extracted from
the saliva samples. All coding exons and intron-exon boundaries of TUBB3 and TUBB2B
and exons 8, 20, and 21 of KIF21A were sequenced as previously reported [4,5,24]. Primer
sequences are available on request.
4.3. Optical Coherence Tomography Acquisition
A handheld SD-OCT (Envisu C2300, Leica Microsystems, Wetzlar, Germany) was used
for imaging the optic nerve head (ONH) and fovea. All images were obtained without seda-
tion. The scan protocols used in this study have been previously described [25,26]. Scanning
windows of 10 × 10 mm (A × B scans: 500 × 100) centered on the fovea and ONH sepa-
rately was used to acquire them. We successfully obtained scans in 15/16 patients (93.7%).
4.4. Optic Nerve Head Analysis
A single B-scan through the deepest part of the optic cup was used for analysis as
described elsewhere [25]. The scans were analyzed using ImageJ software version 1.48 [27].
The horizontal disc diameter was defined as the distance between the edges of Bruch’s
membrane. The cup diameter was determined using a cup offset of 150 µm anterior to
the disc axis. Cup depth was measured as the vertical distance from the cup base to
the midpoint of the neuro-retinal peaks (Supplementary Figure S2 and Figure 4) [25].
The retinal nerve fiber layer (RNFL) thicknesses were calculated at 1.2 mm and 1.8 mm
laterally from the ONH after adjusting for axial length, as described previously [14,25,26].
ONH analyses were performed independently by two authors (MT and MH) blinded to
the diagnosis.
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4.5. Foveal Analysis
The central foveal B-scan was selected based on the scan with the deepest foveal pit
and features of cone photoreceptor specialization [28,29]. The retinal layers were segmented
using a semi-automated ImageJ macro as described elsewhere [26]. Retinal thickness
measurements obtained were the following: RNFL, ganglion cell complex (GCC), inner
nuclear layer (INL), outer plexiform layer (OPL), photoreceptor layer (PRL) (sum of outer
nuclear layer, inner segment, and outer segment), and retinal pigment epithelium (RPE).
At the fovea, we measured the foveal pit depth and pit diameter. For statistical
analyses, we grouped the data as follows: (1) central foveal thickness measurements,
(2) paracentral area (defined as average thickness of each layer 250 µm nasally to 250 µm
temporally from the center), and (3) nasal and temporal areas (defined as average thickness
of each layer 500 µm to 2000 µm from the center, nasally and temporally, respectively)
(Supplementary Figure S3 and Figure 5).
4.6. Retinal Vessel Analysis
We utilized an automated algorithm for segmenting and measuring retinal vessels
from fundus photos, by growing a “Ribbon of Twins” active contour model [30,31]. We
calculated the number of bifurcations and different vessel tortuosity parameters. Features
from each bifurcation (Supplementary Figure S4) were extracted. This included branching
geometry at the bifurcation (angle θ, θ1, and θ2), diameter ratios (α, β, and λ), and
junction exponent (K).
4.7. Statistical Analysis
Statistical analysis was performed using IBM SPSS Statistics software (version 24, IBM
Corp.). A linear mixed model was used to determine significant differences in foveal, ONH,
and vasculature measurements between CFEOM patients and controls. Within the model,
eye (left vs. right) was assigned as a repeated measure, fixed factor was the diagnosis
(CFEOM vs. controls), and random factors included age, gender, ethnicity, and refraction.
Bonferroni correction was applied for multiple testing. p ≤ 0.05 was considered statistically
significant. Intraclass correlation coefficients were calculated for disc width, rim width,
cup width, and cup depth to assess reliability of measurements.
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